Latex Free Claims: A White Paper on the Risks Associated with Latex Allergies and Latex in Healthcare. Brought to you by:
|
|
- Octavia Cross
- 5 years ago
- Views:
Transcription
1 Latex Free Claims: A White Paper on the Risks Associated with Latex Allergies and Latex in Healthcare Brought to you by: Allergy and Asthma Network: Sue Lockwood and Robert Hamilton, M.S., Ph.D. Avella Specialty Pharmacy: Eric Sredzinski, Pharm.D., AAHIVP and Jenna Vaughn, Pharm.D., PGY1
2 Executive Summary There is significant confusion as to the meaning of latex free in healthcare. The FDA has urged manufacturers to drop the term latex free or a does not contain latex claim from labels because of the challenge to ensure a product is completely devoid of natural rubber latex proteins which cause the allergic reactions. While there are no regulations requiring the labeling of a medical product to state natural rubber latex was not used as a material in the manufacturing process, the terms latex free or does not contain latex are used too broadly. According to the FDA, these labeling techniques are not sufficiently specific, not necessarily scientifically accurate, and may be misunderstood and applied too widely. On December 2, 2014, the FDA released the final latex guidance document [ GuidanceDocuments/UCM pdf] advising firms to use not made with natural rubber latex if no natural (Hevea brasiliensis) rubber latex was used in the manufacturing process. Not all types of latex are from natural rubber latex; for example, products that contain nitrile and polyvinyl chloride, will not cause a natural rubber latex allergy because these are synthetic formulations. In 2012, The Journal of Investigational Allergology and Clinical Immunology published a position paper on latex allergy that provides a comprehensive review on latex allergy and reviews processes to identify and manage patients with latex allergies. To best protect patients with a suspected but unverified latex allergy, a detailed patient history on past exposures and reactions must be obtained and documented. For patients with a known latex allergy, any products containing natural rubber latex must be avoided. However, it may be impossible to be 100% confident that a complete natural rubber latex environment can be achieved. Label confusion continues and understanding the labeling techniques as well as the FDA guidance document is key to be informed. If there is a question on the potential natural latex content of a product, the primary vendor or supplier should be contacted for additional information. On December 2, 2014, the FDA released the final latex guidance document advising firms to use "not made with natural rubber latex" if no natural (Hevea brasiliensis) rubber latex was used in the manufacturing process 2
3 Purpose The purpose of this white paper is to educate those involved in healthcare about important issues relating to the use of Hevea brasiliensis latex, latex allergies, and available alternatives. Introduction Latex as raw, natural rubber is harvested from the milky sap of the rubber tree, Hevea brasilienesis, which is principally grown throughout Indonesia, Thailand and Vietnam (2). Latex in its raw form contains 60 polypeptides proteins that have been identified as potentially allergenic, 15 of which are principal allergens (7, Table 1). Hevea latex has become prevalent in modern society because of its resistance to chemicals, elasticity, comfort, ease of manufacturing, and low cost. Due to these benefits, thousands of products contain natural rubber latex and most have the potential to trigger an allergic reaction (Table 2). Latex-caused allergic reactions, seen both in the general population and healthcare workers, are a serious medical concern. The risk of developing a latex allergy increases with repeat exposure and 8 12% of healthcare workers reportedly have developed a sensitivity to natural rubber latex compared to 1 6% of the general population (7). Steps must be taken to ensure that the risk of an allergic reaction is kept at a minimum, and the use of synthetic latex and other alternatives should be considered when feasible. Table 1 Latex Allergens Allergen Hev b 1 and 3 Properties Main allergen in spina bifida patients The risk of developing a latex allergy increases with repeat exposure and 8 12% of healthcare workers reportedly have developed a sensitivity to natural rubber latex compared to 1 6% of the general population Hev b 5 and 6 Hev b 2, 4, 7, and 13 Hev b 6.02 and 7 Hev b 8, 11, and 12 Main allergen in healthcare workers Secondary allergen in healthcare workers Seen in allergen cross-reactivity with fruits Panallergens with unknown cross-reactivity with fruits Table 2 Latex: Common and Medical Common Items Containing Hevea Latex Healthcare Items Containing Hevea Latex Balloons Catheters Compression Stockings Condoms Syringes Stethoscopes Toys Vial Stoppers Masks Erasers Bandages Tape Rubber Bands Gloves Adhesives Sports Balls (Tennis, Basketball) Blood Pressure Cuffs Injection Ports Therapy Bands Rubber Accelerators Electrode Pads Elastic 3
4 Latex Allergies In the late 1980s, universal precautions in healthcare were introduced to prevent the spread of HIV. The use of latex gloves and other protective devices also increased, leading to an explosion of allergies of epidemic proportions. Healthcare workers are naturally at a greater risk for developing latex allergies due to repeat exposure to latex-containing gloves and medical equipment. However, after peaking in the mid-1990s, latex allergies have been on the decline with the increased use of synthetic substitutes and increased awareness of the risks associated with latex. The allergenic proteins found within the latex of natural rubber and the chemicals added in the manufacturing process can lead to three types of adverse effects: irritant contact dermatitis, allergic contact dermatitis, and immediate-type allergic reactions (4, Table 3). Irritant contact dermatitis is a non-allergic, localized inflammation of the skin caused by chemical irritation and not by latex allergens. Allergic contact dermatitis, known as type IV hypersensitivity, is limited to the skin and is a T-cell mediated reaction to chemicals added during production. Irritant contact dermatitis and type IV reactions are both marked by redness, lesions, or itching, which weakens the skin barrier and allows allergens easy access into the body. Immediate-type allergic reactions, known as type I hypersensitivities, are mediated by the Hevea latex-specific IgE antibodies in response to exposure to latex proteins. These can be deadly, with a 1% lethality rate. Type I reactions are caused by the release of histamine and leukotrienes from mast cells. Symptoms include: itching, papules, angioedema, asthma, and anaphylaxis (5). Table 3 Reactions to Latex Reaction Type Symptoms Cause Time of Onset Immediate hypersensitivity (Type I) Urticaria (hives), nausea, vomiting, rhinitis, conjunctivitis, bronchospasms, and anaphylactic shock Latex allergens -15 known types Immediate and within minutes Allergic contact dermatitis (Type IV) Rash, itching, vesicles, redness, and blisters Chemicals/rubber accelerators in latex Delayed, takes up to 48 hours after contact Irritant contact dermatitis Dry, cracked, red, and irritated skin Chemicals/rubber accelerators in latex Gradual and over several days Routine testing of all patients and healthcare workers who are at risk or suspected of having a latex allergy is essential to preventing a reaction. Latex allergy testing includes the patch test, skin prick, intradermal test, IgE antibody immunoassays, and a use (glove application challenge) test (1). The patch test is used to detect irritant contact dermatitis in patients and involves placing a patch with latex chemicals on a patient s skin for 2-3 days. The puncture/prick skin test looks for type I reactions; to perform it, a drop of latex extract is scratched into a patient s skin. An intradermal test is similar to a prick test as a latex solution is inserted into the skin and the patient is observed for a type I reaction. Intradermal tests must be performed cautiously as they generate higher levels of allergic reactions and have the potential to trigger anaphylaxis. Importantly, neither a puncture nor 4
5 intradermal skin test can be performed in the United States due to an absence of an FDA-cleared Hevea latex skin testing reagent. Thus, IgE immunoassays that are used to detect the presence of Hevea latex specific-ige antibodies in a patient s serum are the only confirmatory test available at present in the USA. However, latex skin test reagents are available elsewhere in the world. If a serological assay for IgE antibody is negative but the patient has reported symptoms of a latex allergy, then a simple use test may be cautiously performed. With a use test, the fingertip of a latex glove is dampened and then placed upon a patient s hand for 15 minutes. If the patient does not react to the fingertip, then the entire dampened latex glove is placed on the patient for another 15 minutes and they are observed for a reaction. The efficacy of this use test is highly dependent on the Hevea latex content in the glove used for the evaluation. Latex skin prick testing through a glove is NOT recommended in the United States, due to many reported adverse reactions. So, physicians must rely on clinical judgement and by obtaining an individual s history, including association between latex exposure and the development of symptoms. If a patient begins to show signs or symptoms of a natural rubber latex allergy, then swift action is important to preventing further injury (1). For an irritant or allergic contact dermatitis reaction, washing the area with soap and water will quickly remove the allergen. If the rash is significant, the next step is to apply topical corticosteroids or hydrating creams to ease pain, inflammation, and itching. Dangerous type I reactions require immediate attention by removing the individual from the offending substance, washing the area of contact, monitoring vital signs, and administering emergency treatment if needed. Medications that may be used during an allergic reaction are antihistamines for mild to moderate symptoms, oral or topical steroids, and epinephrine for reversing the severe symptoms of anaphylaxis. Multiple routes of latex exposure can trigger a reaction, such as contact with the body s mucous membrane, skin, open wounds, surgical or IV exposure, and inhalation of latex proteins. Cornstarch, a common ingredient in powdered latex gloves, binds latex proteins and allows the resulting powder to become aerosolized in a room, triggering inhalation-related allergic responses (5). The accelerator chemicals used in latex production, frequent handwashing, soaps, and detergents can further irritate the hands of healthcare workers and increases the risk of an allergic reaction. Certain high-risk populations require extra precautions in healthcare settings to prevent latex exposure (7, Table 4). Spina bifida patients are at a particularly high risk, as they require multiple surgeries throughout their life. Historically 12-73% developed latex allergies, especially during the peak epidemic of latex allergen exposure In the 1990s (1). Patients who have food allergies to bananas, avocados or kiwi fruit are at risk as well due to cross-reactivity between IgE antibodies. Healthcare workers who have constant exposure to latex gloves and other forms of equipment are at risk, although this has decreased in recent years with the rise of synthetic latex products. Importantly, neither a puncture nor intradermal skin test can be performed in the United States due to an absence of an FDA-cleared Hevea latex skin testing reagent 5
6 Table 4 Latex Allergies Among High Risk Populations with High Latex Exposure Latex Allergy Population Patients Country Year Reported 11.4% Elderly Patients 88 Italy % Spina Bifida Patients 35 Singapore % Myelomeningocele Patients 55 Brazil % Healthcare Students 619 Italy % Healthcare Workers 4529 Thailand % Nurses 899 Thailand % Healthcare Workers 804 USA 2012 Latex and Synthetic Use in a Healthcare Setting The only way to decrease the risk of developing an allergic reaction is to prevent exposure, as there is no cure for latex sensitivity. When working with patients who have latex allergies, healthcare personnel must make efforts to ensure a latex-safe environment prior to visits. Scheduling the patient to have the first appointment of the day reduces the risk of latex exposure, as does removing latex-containing supplies from the room (4). Unfortunately, due to the nature of latex, it is often difficult to eliminate all traces from a product or location. On December 2, 2014, the FDA issued a document to guide healthcare facilities in labeling their items with regards to latex use (6). This document applies to all FDA regulated medical products where natural rubber latex or synthetic derivatives of natural rubber latex were not used as materials in their manufacture; or any container and/or packaging that was not made with natural rubber latex or synthetic derivatives of natural rubber latex. The FDA issued this guidance document in part because healthcare facilities were labeling their products with statements such as latex free, does not contain natural rubber latex, or does not contain latex. These statements are false and misleading, as there are no analytical methods to identify all the proteins and chemicals in latex that may trigger an allergic reaction. Instead, the FDA recommends that healthcare facilities use terminology such as not made with natural rubber latex. In certain situations, only part of the product may not have been made with Hevea rubber latex and should include more specific labels such as the <vial stopper> is not made with natural rubber latex. There are no analytical methods to identify all the proteins and chemicals in latex that may trigger an allergic reaction To create a latex-safe environment, healthcare facilities should use synthetic latex alternatives to prevent contamination of equipment, rooms and clothing. Sometimes contact with latex is unavoidable, as is often seen with medical necessities, such as vials containing natural rubber latex 6
7 stoppers (3). In 1997, latex stoppers were deemed by the FDA to pose no significant risk for individuals with latex sensitivity based on testing using the Lowry assay. However, it has been subsequently determined that the Lowry assay is not sensitive enough to detect low levels of latex allergens within vial stoppers. Due to this, many hospitals began to pop the top of vial stoppers prior to use to avoid latex contamination. The problem with this method is that it is possible that latex leaches from vial stoppers into the medication and the open top exposes the contents to microbial contamination. In an attempt to limit latex exposure, some hospitals initiated a single stick rule, with a single stick allowed per stopper to maintain a closed system environment for the medication and theoretically limit latex leaching. To date, there are few studies available to determine whether latex allergen risk is significantly lowered by either the pop the top technique or the, single stick rule with latex-topped vials. It is up to the individual organization to determine which method they would prefer, noting that the American Association of Nurse Anesthetists employs the pop the top method for at-risk patients and the American Academy of Allergy Asthma and Immunology suggests the single stick rule. Synthetic polymers such as neoprene, polyisoprene, butadiene, and elastiprene gloves are all recommended for surgical procedures, but are expensive A 2005 masked prospective clinical study by Hamilton et al. explores the use of the single stick rule. This study used 5 different types of vial stoppers, ranging from synthetic to full latex, punctured 1-40 times (3). The study involved 23 patients, 12 of whom had confirmed latex allergies, and all had received puncture and intradermal skin tests with solutions from Hevea latex-stoppered vials. Of the 12 latex-sensitive patients, two had reactions to the one puncture stoppers, and five reacted to the 40 puncture stoppers. Based on these results, Hamilton recommends that healthcare facilities employ the single stick rule when dealing with latex-containing stoppers and to take special precautions in high risk individuals. Latex gloves are another source of allergens and are amongst the most common triggers for allergic reactions in both patient and healthcare worker alike. Since the 1990s, several synthetic alternatives to latex gloves have been created, such as neoprene, polyvinyl chloride, silicone, and polyurethane (2). However, not all gloves used in healthcare are made equally with regards to cost, comfort, use, or protection. Vinyl gloves have not been found to have the same barrier quality as latex and may have a decreased protection against infective agents. Nitrile gloves offer similar levels of protection and infection resistance when compared to latex. Synthetic polymers such as neoprene, polyisoprene, butadiene, and elastiprene gloves are all recommended for surgical procedures, but are expensive. While each type of synthetic glove differs with regard to both strengths and weaknesses, all have the benefit of not containing latex. Other types of gloves contain low levels of latex allergens, have a reduced risk for triggering a reaction, and are powder free to prevent inhalation. Allergies among healthcare workers have been decreasing around the world since their peak in the 1990s thanks to the availability of latex alternatives. Multiple studies have also shown a reduction in latex sensitivity with the reduced use of latex (5). A 2002 study from the Mayo Clinic shows a significant A 2002 study from the Mayo Clinic shows a significant decrease in latex allergies from 150 cases per 100,000 healthcare workers to a mere 27 cases since
8 decrease in latex allergies from 150 cases per 100,000 healthcare workers to a mere 27 cases since A study of seven German hospitals noted a similar outcome, with a decrease of 68 cases of latex allergies per 100,000 healthcare workers to 21 cases since With the rise of latex alternative products, healthcare facilities are now more capable than ever to develop the latex safe protocol necessary to protect both employees and patients. Table 5 includes a list of websites that offer the first steps towards reducing the risk of latex allergies with topics including current clinical management, educational resources, and available alternative products (1, Table 5). Table 5 Latex Alternative Resources and Information Organization Information Website Allergy & Asthma Network (AAN) American Academy of Allergy Asthma & Immunology Latex allergy educational resources Latex alternatives for both consumers and healthcare facilities Allergy information and protocol American Association of Nurse Anesthetists (AANA) American College of Allergy, Asthma & Immunology (ACAAI) Guidelines for latex allergy management Guidelines for the management of latex allergies and safe latex use in health care facilities (Sussman &, Gold) professionalpractice/pages/latex- Allergy-Protocol.aspx Conclusions To best protect patients with an unknown natural latex allergy, a detailed patient history on past exposures and reactions must be obtained and documented. When working with patients who have latex allergies, healthcare personnel must make efforts to ensure a latex-safe environment prior to visits. Hospitals and pharmacy facilities should consider adopting the single stick rule with latex-stoppered vials to lower the risk of latex allergen exposure for employees and patients. Resources 1. Binkley, Helen M., Traci Schroyer, and Jennifer Catalfano. Latex Allergies: A Review of Recognition, Evaluation, Management, Prevention, Education, and Alternative Product Use. Journal of Athletic Training 38.2 (2003): PubMed. Web. 24 Feb Cabanes, N., J. M. Igea, and B. Hoz. Latex Allergy: Position Paper. J Investig Allergol Clin Immunol 22.5 (2012): Web. 21 Feb Hamilton, Robert G., et al,. Administering pharmaceuticals to altexallergic patients from vials containing natural rubber latex closures. Am J Health-Syst Pharm 62 (2005): Web. 4. Pollart, Susan, Crista Warniment, and Takahiro Mori. Latex Allergy. American Family Physician (2009): Web. 8
9 5. Ranta, Peter M., and Dennis R. Ownby. A Review of Natural-Rubber Latex Allergy in Health Care Workers. Clin Infect Dis 38.2 (2004): Oxford Academic. Web. 24 Feb Recommendations for Labeling Medical Products to Inform Users That the Product or Product Container Is Not Made with Natural Rubber Latex: Guidance for Industry and Food and Drug Administration Staff. U.S. Department of Health and Human Services (December 2, 2014): 1-5. Food and Drug Administration. 28 Feb Centers for Disease Control and Prevention (CDC). Latex allergy. Retrieved from: toolstemplates/entertainmented/tips/latexallergy.html 8. Food and Drug Administration. (December 2nd, 2014). Recommendations for Labeling Medical Products to Inform Users that the Product or Product Container is not Made with Natural Rubber Latex Guidance for Industry and Food and Drug Administration Staff. Retrieved from downloads/medicaldevices/deviceregulationandguidance/ GuidanceDocuments/UCM pdf 9. Food and Drug Administration. (March 30th, 2015). Don t be misled by latex Free claims. Retrieved from ForConsumers/ConsumerUpdates/ucm htm With the rise of latex alternative products, healthcare facilities are now more capable than ever to develop the latex safe protocol necessary to protect both employees and patients Glossary of Terms 1. Allergen: a substance, often a protein that induces an allergy. 2. Panallergan: families of related proteins, such as the HEV proteins in the rubber tree plant 3. IgE: Immunoglobulin E is a class of antibodies that mediate an allergic reaction 4. Antibodies: proteins produced in the blood in response to the presence of an antigen 5. Rhinitis: inflammation of the mucus lining of the nose 6. Conjunctivitis: inflammation of the transparent surface of the eye (conjunctiva) 7. Immunoassays: a laboratory technique to identify and quantify a protein 8. Corticosteroids: natural or synthetic hormones that assist in the homeostasis of the body 9. Anaphylaxis: a sudden, usually allergic reaction, induced by exposure to a secondary exposure to a foreign substance, such as an antigen 10. Lowry assay: a biochemical assay (test) for determining the total level of protein in a solution 11. Microbial: a microorganism 12. Nitrile: an organic compound 9
10 About the Authors Sue Lockwood Latex Allergy Expert & Co-Founder of the Former American Latex Allergy Association A leader in Latex Allergy & Co-Founder of the Former American Latex Allergy Association, Lockwood co-founded the American Latex Allergy Association, a nationwide latex allergy support organization that closed in 2016 after 23 years. She has now joined Allergy & Asthma Network expanding the Network s reach in Latex Allergy and Outreach Services. She has worked closely with allergy researchers and latex glove companies, and partnered with leading allergy organizations, including the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma & Immunology, to provide evidence-based resources. Allergy & Asthma Network is the leading national nonprofit organization dedicated to ending needless death and suffering due to asthma, allergies, and related conditions. Allergy & Asthma Network specializes in sharing family-friendly, medically accurate information through its award-winning publication Allergy & Asthma Today magazine, E-newsletter, AllergyAsthmaNetwork.org, and numerous community outreach programs. Robert Hamilton, M.S., Ph.D. Director, Dermatology, Allergy & Clinical Immunology (DACI) Reference Laboratory Professor of Medicine Robert G. Hamilton, Ph.D., D(ABMLI) is currently Professor of Medicine and Pathology at The Johns Hopkins University School of Medicine in Baltimore, Maryland. He joined the Division of Allergy and Clinical Immunology of the Department of Medicine in 1981 and is the Director of the Dermatology-Allergy Clinical Immunology (DACI) Reference Laboratory. He is a fellow of the American Academy and College of Allergy, Asthma and Immunology. He has served as co-editor the past 2 editions of the Manual of Molecular and Clinical Laboratory Immunology. He has authored more than 300 peer-reviewed publications, reviews and book chapters. He lectures on a variety of topics, including laboratory diagnosis and management of human allergic disease and assessment of immunogenicity and allergenicity of new drugs. Eric Sredzinski, Pharm.D., AAHIVP Avella Specialty Pharmacy, EVP, Clinical Affairs & Quality Assurance Pharmacy Program Director, ADAP Dr. Eric Sredzinski is responsible for the clinical management, disease state management, training, and implementation of patient adherence and persistence programs for Avella Specialty Pharmacy. Working closely with the company s oncology, infectious disease, and transplant teams for presentations and business development, Dr. Sredzinski, a member of Avella Specialty Pharmacy s top management since joining the company in 2001, is also responsible for the management of manufacturer contracted data sets, including the participation in the development and testing of the data layout. Dr. Sredzinski is an active member of ASHP, The Arizona Pharmacists Association, HOPA, ASCO, and the AAHIVP. 10
11 Jenna Vaughn, Pharm.D. Pharmacy Resident Avella Specialty Pharmacy As a PGY1 resident for the Avella Specialty Pharmacy, Dr. Jenna Vaughn is involved in a variety of different rotations within the company involving areas such as: direct patient care, compounding, clinical education, limited distribution, business development, and pharmacy management. Dr. Vaughn spends her time working within different departments throughout several Avella locations and has gained valuable experience with HIV, fertility, pain, and oncology specialty medications. Dr. Vaughn is also responsible for co-teaching an Introduction to Specialty Pharmacy class at the Arizona Midwestern University with the residency program director and director of clinical services, Kelly Mathews. Dr. Vaughn recently graduated from the University of Colorado School of Pharmacy on May, 2016 with a Doctor of Pharmacy degree and entered into the Avella residency shortly after. Dr. Vaughn has spent this last year focusing on her residency and intends to continue working in specialty pharmacy once it has ended. Prior to graduation, Dr. Vaughn worked as an intern at a King Soopers with a strong HIV department and volunteered at the University of Colorado Hospital pharmacy in her free time. About Allergy & Asthma Network Allergy & Asthma Network is the leading national nonprofit organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions. Allergy & Asthma Network specializes in sharing family-friendly, medically accurate information through its awardwinning publication Allergy & Asthma Today magazine, E-newsletter, AllergyAsthmaNetwork.org and numerous community outreach programs. Follow Allergy & Asthma Network on Facebook and Join the Network at AllergyAsthmaNetwork.org/join. About Avella Specialty Pharmacy Headquartered in Phoenix, Arizona, Avella Specialty Pharmacy is a National Accredited Specialty Pharmacy, providing individualized care and support to patients since Avella s clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The company offers a nationwide distribution service to complement its retail locations. In 2016, Avella was named Specialty Pharmacy of the Year by NASP, a nationally recognized pharmacy trade committee. Inc. Magazine s 2016 list of the 5,000 fastest-growing private companies in the country included Avella for the tenth consecutive year and also recognized Avella as the fastest-growing woman-led company in For more information, please visit 11
12 Connect with Allergy and Asthma Network allergyasthmanetwork.org Connect with Avella avella.com facebook.com/avellarx lb6ass5p
LATEX ALLERGIES. As with many other natural products, natural rubber latex contains proteins to which some individuals may develop an allergy.
What is Natural Rubber Latex? LATEX ALLERGIES Natural rubber latex (NRL) is a milky fluid obtained from the Heva barsiliensis tree, which is widely grown in South East Asia and other countries. NRL is
More informationHealthStream Regulatory Script
HealthStream Regulatory Script Latex Allergy Release Date: August 2009 HLC Version: 602 Lesson 1: Introduction Lesson 2: Risk Factors & Diagnosis Lesson 3: Types of Latex Reactions Lesson 4: Managing Latex
More informationPROTECT YOURSELF FROM TYPE I ALLERGIES.
PROTECT YOURSELF FROM TYPE I ALLERGIES. 1 PROTECT YOURSELF FROM TYPE I ALLERGIES. Occasionally wearing glove products can cause issues with the health of our skin. This predominantly manifests itself in
More informationCross Country University s Caregiver Safety Series. Latex Allergy. Background to Latex Allergy
Latex Allergy Background to Latex Allergy What is latex? Latex is a rubber compound found in many products that you use on your job. It is produced from rubber trees in the Tropics. The most common medical
More informationGUIDE TO... Latex allergy. Learning outcomes. This guide is supported by an educational grant from
GUIDE Janet Pickles is Chairwoman, RA Medical Services Ltd, Steeton, West Yorkshire Email: janet@ramedical.com TO... Learning outcomes After reading this Guide to Latex Allergy you should: n Understand
More informationGLOVE ALLERGIES AND HAND HEALTH
GLOVE ALLERGIES AND HAND HEALTH INTRODUCTION Skin conditions caused by chemical, physical or biological agents in the workplace are common among disposable glove wearers in the industrial sector. Understanding
More informationLATEX ALLERGY ASCIA Education Resources patient information
LATEX ALLERGY ASCIA Education Resources patient information Allergies to latex rubber have only been recognised in the last 20 years. The reasons are uncertain, although increased use of latex gloves in
More informationVELINDRE NHS TRUST. REF: Black 46. Trust Policy
VELINDRE NHS TRUST REF: Black 46 POLICY FOR THE MANAGEMENT OF LATEX AND LATEX ALLERGY Health and Safety Manager Ref: Black 46 Page 1 of 14 CONTENTS Executive Summary Page 3 1. Introduction Page 4 2. Scope
More informationLatex and Occupational Dermatitis Policy Incorporating Glove Selection
Latex and Occupational Dermatitis Policy Incorporating Glove Selection DOCUMENT CONTROL: Version: 3 Ratified by: Risk Management Sub Group Date ratified: 17 July 2013 Name of originator/author: Health
More informationA Review of the Expert Opinion on Latex Allergy
A Review of the Expert Opinion on Latex Allergy Author(s) Pete Phillips BPharm, MRPharmS, DMS (Health) Deputy Director Surgical Materials Testing Laboratory Princess of Wales Hospital, Bridgend, Wales.
More informationSARASOTA MEMORIAL HEALTH CARE SYSTEM CORPORATE POLICY
SARASOTA MEMORIAL HEALTH CARE SYSTEM CORPORATE POLICY TITLE: LATEX ALLERGY POLICY #: EFFECTIVE DATE: REVIEWED/REVISED DATE: POLICY TYPE: 5/28/97 08/25/17 Clinical 1 of 5 Non-Clinical Job Title of Responsible
More informationAbdul Kadir, Ph D Deputy Chief Executive Officer. Malaysian Rubber Export Promotion Council
Know your medical gloves for better protection and patient care Abdul Kadir, Ph D Deputy Chief Executive Officer Malaysian Rubber Export Promotion Council Outline What are medical gloves? How gloves prevent
More informationTony Gray Head of Safety and Security. Tony Gray Head of Safety and Security. Contents Section Description Page No.
Health and Safety Policy Practice Guidance Note Latex Sensitivity V04 Date Issued Planned Review Issue 1 Oct 17 Oct 2020 HS-PGN-10 Part of NTW(O)20 Health and Safety Policy Author/Designation Tony Gray
More informationProtecting patients and staff
PBy Sharon E. Hohler, BSN, RN, CNOR Perioperative nurses should have a good understanding of the science of latex allergies and how to protect patients and healthcare professionals (HCPs) when updating
More informationMyth: Prior Episodes Predict Future Reactions REALITY: No predictable pattern Severity depends on: Sensitivity of the individual Dose of the allergen
Myth: Prior Episodes Predict Future Reactions REALITY: No predictable pattern Severity depends on: Sensitivity of the individual Dose of the allergen Anaphylaxis Fatalities Estimated 500 1000 deaths annually
More informationfeeling Stay in touch with your second skin
safe A feeling Stay in touch with your second skin A breakthrough solution Latex allergy explained Total Glove Company Sdn Bhd (Total Glove) is the joint venture company of Latexx Partners Bhd and the
More informationAccommodation and Compliance Series. Employees with Latex Allergy
Accommodation and Compliance Series Employees with Latex Allergy Preface The Job Accommodation Network (JAN) is a service of the Office of Disability Employment Policy of the U.S. Department of Labor.
More informationKnow your gloves for better infection control
Know your gloves for better infection control Abdul Kadir, Ph D Deputy Chief Executive Officer Malaysian Rubber Export Promotion Council Outline How gloves prevent infections What are medical gloves? Glove
More informationThe worry-free choice...
Healthcare-Associated Infection Solutions KIMBERLY-CLARK* STERLING* Nitrile Exam Gloves The worry-free choice...... designed for use by everyone, everywhere. Latex-quality Performance in a Worry-free,
More informationTextile Chemist and Colorist & American Dyestuff Reporter. Vol. 32, No. 1, January Safe Handling of Enzymes
Textile Chemist and Colorist & American Dyestuff Reporter Vol. 32, No. 1, January 2000 Safe Handling of Enzymes By the Enzyme Technical Association, Washington, D.C. Enzymes have been used for over 35
More informationAllergy/Immunology Marshall University Pediatrics
Allergy/Immunology Marshall University Pediatrics Description: This is a clinical rotation about the most common chronic diseases affecting both children and adults. Residents will be introduced to allergy,
More informationAn Overview of Latex Allergies for the CNA
An Overview of Latex Allergies for the CNA This course has been awarded three (3.0) contact hours. This course expires on September 30, 2018. Copyright 2012 by RN.com. All Rights Reserved. Reproduction
More informationDate Ratified 15/05/2014 Health & Safety Committee Review Date 01/05/2016 Director of Estates and Facilities Expiry Date 14/05/2017 Withdrawn Date
Policy No: RM15 Version: 5.0 Name of Policy: Latex Policy Effective From: 19/06/2014 Date Ratified 15/05/2014 Ratified Health & Safety Committee Review Date 01/05/2016 Sponsor Director of Estates and Facilities
More informationPrevention And Management Of Latex Sensitisation And Allergy For Patients
Prevention And Management Of Latex Sensitisation And Allergy For Patients Contents Policy... 1 Purpose... 1 Scope/Audience... 1 Associated documents... 1 Latex Free Guides... 2 Management of Patient with
More informationImmunocompetence The immune system responds appropriately to a foreign stimulus
Functions of the immune system Protect the body s internal environment against invading organisms Maintain homeostasis by removing damaged cells from the circulation Serve as a surveillance network for
More informationIn partnership with: Cardinal Health Exam Gloves. When it comes to safety and comfort, we ve got you covered.
In partnership with: Cardinal Health Exam Gloves When it comes to safety and comfort, we ve got you covered. Contents Cardinal Health and Henry Schein are partnering together to provide care to your patients,
More informationBloodborne Pathogens Key Topic for 2015 Gloves The First Line of Defense
Key Topic for 2015 In 2014, the Occupation Health & Safety (OH&S) course focused on the first line of defense - gloves. The information covers: 1. Determining the different types of gloves for specific
More informationWest Houston Allergy & Asthma, P.A.
Consent to Receive Immunotherapy (ALLERGY SHOTS) Procedure Allergy injections are usually started at a very low dose. This dose is gradually increased on a regular (usually 1-2 times per week) basis until
More informationEUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL GUIDELINES ON MEDICAL DEVICES
Ref. Ares(2015)2057675-18/05/2015 EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single Market : regulatory environment, standardisation and New Approach Pressure equipment, medical devices, metrology
More informationHealthcare Professionals and Medical Gloves
Healthcare Professionals and Medical Gloves Healthcare professionals are constantly exposed to potentially harmful infectious agents, e.g. HIV, Hepatitis B & C, and Ebola. They need protection during their
More informationDermatitis. Occupational aspects of management
Dermatitis Occupational aspects of management Evidence-based guidance for healthcare professionals Introduction This leaflet summarises the findings from a review of the published scientific literature
More informationHypersensitivity Reactions and Peanut Component Testing 4/17/ Mayo Foundation for Medical Education and Research. All rights reserved.
1 Hello everyone. My name is Melissa Snyder, and I am the director of the Antibody Immunology Lab at the Mayo Clinic in Rochester, MN. I m so glad you are able to join me for a brief discussion about the
More informationSubj: PREVENTION OF LATEX SENSITIZATION AND MINIMIZING ITS EFFECTS AMONG HEALTH CARE WORKERS AND PATIENTS
DEPARTMENT OF THE NAVY BUREAU OF MEDICINE AND SURGERY 7700 ARLINGTON BOULEVARD FALLS CHURCH, VA 22042 IN REPLY REFER TO BUMEDINST 6200.16A BUMED-M3 BUMED INSTRUCTION 6200.16A From: Chief, Bureau of Medicine
More informationLatex Allergy - the Australian experience Where are we now Prof CH Katelaris University of Western Sydney and Campbelltown Hospital
Latex Allergy - the Australian experience Where are we now Prof CH Katelaris University of Western Sydney and Campbelltown Hospital Latex conf Dec Latex Allergy - Australian Experience Clinical studies
More informationExamination. Surgical. Protective 380/GB/ / Abena Group Marketing BR
Gloves Examination. Surgical. Protective Gloves Abena s expert knowledge and experience help you select the best glove for specific needs. The most important parameter when choosing a glove is the intended
More informationLatex allergy in health care workers: prevalence and knowledge at a tertiary teaching hospital in a developing country
International Journal of Infection Control www.ijic.info ISSN 1996-9783 original article Latex allergy in health care workers: prevalence and knowledge at a tertiary teaching hospital in a developing country
More informationTHE NON PENICILLIN BETA LACTAM DRUG CROSS CONTAMINATION PREVENTION; USFDA PERSPECTIVE
THE NON PENICILLIN BETA LACTAM DRUG CROSS CONTAMINATION PREVENTION; USFDA PERSPECTIVE An overview by Sarah Vugigi, M. Pharm, Elys Chemical Industries Ltd, Nairobi, Kenya INTRODUCTION This guidance describes
More informationAllergy Medications. Antihistamines. are very safe. Although usually taken as tablets, they may be prescribed as a liquid or syrup for young children
The treatments prescribed for allergy control the symptoms and reactions; they do not cure the condition. However, using treatments as prescribed can show a huge change in a patient s health, mood and
More informationDental surgeons with natural rubber latex allergy: a report of 20 cases
Occup. od. Vol. 49,. 2, pp. 103-107, 1999 Copyright C 1999 LJpptncott Williams 4 WilkJns for SO Printed In Great Britain. AH rights reserved 0962-7480/99 Dental surgeons with natural rubber latex allergy:
More informationAllergy & Anaphylaxis
Allergy & Anaphylaxis (why, where, and what to do) Robert H. Brown, M.D., M.P.H. Professor Departments of Anesthesiology, Environmental Health Sciences, Medicine, and Radiology The Johns Hopkins Medical
More informationPerioperative Anaphylaxis. Aleena Banerji, MD AAAAI 2014 San Diego, California
Perioperative Anaphylaxis Aleena Banerji, MD AAAAI 2014 San Diego, California Objectives Better understand the differential diagnosis of perioperative anaphylaxis Evaluate and manage patients with a history
More informationClinico Pathological Test SCPA605-Essential Pathology
Clinico Pathological Test SCPA605-Essential Pathology Somphong Narkpinit, M.D. Department of Pathogbiology, Faculty of Science, Mahidol University e-mail : somphong.nar@mahidol.ac.th Pathogenesis of allergic
More informationFood Allergy Testing and Guidelines
Food Allergy Testing and Guidelines Dr Gosia Skibinska Primary Care Allergy Training Day, 15 th October 2011 Food Allergy Testing and Guidelines Food allergy Testing Guidelines Cases Food Allergy NICE
More informationMedical Documentation/Records. ADVERSE DRUG REACTIONS (ADRs) AND ALLERGIES TO MEDICATIONS
FLORIDA STATE HOSPITAL OPERATING PROCEDURE NO. 151-24 STATE OF FLORIDA DEPARTMENT OF CHILDREN AND FAMILIES CHATTAHOOCHEE, April 26, 2017 Medical Documentation/Records ADVERSE DRUG REACTIONS (ADRs) AND
More informationAllergy Management Policy
Allergy Management Policy Food Allergy People with allergies have over-reactive immune systems that target otherwise harmless elements of our diet and environment. During an allergic reaction to food,
More informationSafe Use of Latex Policy
Safe Use of Latex Policy Lead Manager: Andy Crawford- Head of Clinical Governance Responsible Director: Jointly by: Director of Human Resources Medical Director Approved by: Jointly by: Health & Safety
More informationEASTERN ILLINOIS UNIVERSITY OCCUPATIONAL HEALTH FOR STUDENTS
EASTERN ILLINOIS UNIVERSITY OCCUPATIONAL HEALTH FOR STUDENTS The Public Health Service of the U.S. Department of Health and Human Services has directed research/teaching institutions to develop programs
More informationFood Allergens. Food Allergy. A Patient s Guide
Food Allergens Food Allergy A Patient s Guide Food allergy is an abnormal response to a food triggered by your body s immune system. About 3 percent of children and 1 percent of adults have food allergy.
More informationNorovirus in Healthcare Settings
ST. JAMES HEALTHCARE DECEMBER 2012 INFECTION PREVENTION NEWSLETTER INSIDE THIS ISSUE: Norovirus in Healthcare Settings The Impacts of Unsafe Medical Injections in the U.S. Preparing Your Skin Before Surgery:
More informationAllergic Reactions to Vaccines Seminar 1819 San Antonio February 22, 2013
Allergic Reactions to Vaccines Seminar 1819 San Antonio February 22, 2013 John M Kelso, MD Division of Allergy, Asthma and Immunology Scripps Clinic San Diego CA Clinical Professor of Pediatrics and Internal
More informationLatex Allergy Management Guidelines
Latex Allergy Management Guidelines Overview Definition of Latex Allergy In recent years, natural rubber latex (NRL or latex) allergy has been recognized as a significant problem for both patients and
More informationProtective Glove Standard: Selection and Use
Protective Glove Standard: Selection and Use In many University workplaces, exposure to chemicals, infectious agents, sharp objects, extreme temperatures and other hazards can create a potential for injury
More informationSafety Executive (2005), Personal Protective Equipment Regulations (1992) CQC Fundamental Standards: 17
PREVENTION AND MANAGEMENT OF LATEX ALLERGY IN HEALTHCARE WORKERS Policy Register No: 04089 Status: Public Developed in response to: Best Practice, COSHH Regulations (2002), Health and Safety Executive
More informationPolicy for the Treatment of Anaphylaxis in Adults and Children
Policy for the Treatment of Anaphylaxis in Adults and Children June 2008 Policy Title: Policy for the Treatment of Anaphylaxis in Adults or Children Policy Reference Number: PrimCare08/17 Implementation
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 29 February 2012
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 29 February 2012 SOLUPRICK NEGATIVE CONTROL, solution for skin-prick test 1 vial of 2 ml (CIP code: 388 794-3) SOLUPRICK
More informationGLOVES. Getting a grip on infection control. a complete guide for every exposure level
E D U C A T I O N A L S E R I E S GLOVES Getting a grip on infection control a complete guide for every exposure level TIDI understands that choosing what gloves to wear, how to wear them, and knowing
More informationAdverse Reactions to Latex Gloves Among Dentists in Bhubaneswar, Odisha
Research Article J Res Adv Dent 2014; 3:1:55-59. Adverse Reactions to Latex Gloves Among Dentists in Bhubaneswar, Odisha Gunjan Kumar 1* Md Jalaluddin 2 Dhirendra K Singh 3 CL Dileep 4 Purnendu Rout 5
More informationXolair. Xolair (omalizumab) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.45.02 Subject: Xolair Page: 1 of 6 Last Review Date: March 18, 2016 Xolair Description Xolair (omalizumab)
More informationADVERSE REACTION TO LATEX CONTAINING MATERIALS IN HEALTH CARE WORKERS
ORIGINAL REPORT ADVERSE REACTION TO LATEX CONTAINING MATERIALS IN HEALTH CARE WORKERS Gh. Pouryaghoub, R. Mehrdad and M. M. Mazhari Department of Occupational and Environmental Medicine, School of Medicine,
More informationXolair. Xolair (omalizumab) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.45.02 Subject: Xolair Page: 1 of 7 Last Review Date: September 15, 2016 Xolair Description Xolair (omalizumab)
More informationThe worry-free choice...
Healthcare-Associated Infection Solutions KIMBERLY-CLARK* STERLING* Nitrile Exam Gloves The worry-free choice...... designed for use by everyone, everywhere. Latex-quality Performance in a Worry-free,
More informationBOHRF BOHRF BOHRF BOHRF
Occupational Contact Dermatitis and Urticaria A Guide for General Practitioners and Practice Nurses March 2010 British Occupational Health Research Foundat ion This leaflet summarises the key evidence
More informationFDA/NSTA Web Seminar: Teach Science Concepts and Inquiry with Food
LIVE INTERACTIVE LEARNING @ YOUR DESKTOP FDA/NSTA Web Seminar: Teach Science Concepts and Inquiry with Food Thursday, November 15, 2007 Food allergy Stefano Luccioli, MD Office of Food Additive Safety
More informationAllergy & Asthma Day Capitol Hill 2018
Allergy & Asthma Day Capitol Hill 2018 Allergy & Asthma Network ( Network ) is the nation s leading voice and patient advocate for more than 50 million Americans with allergies and 24 million with asthma.
More informationPath2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio
Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY Dr. Erika Bosio Research Fellow Centre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research University of Western Australia
More informationLatex Allergy. Inside this Issue
Latex Allergy Latex sensitivity is used to describe allergic reactions related to the use of products containing latex rubber. In recent years there has been an increase in the number of people who have
More informationPersia Pourshahnazari MD, FRCPC Clinical Immunology and Allergy November 3, 2018
Persia Pourshahnazari MD, FRCPC Clinical Immunology and Allergy November 3, 2018 UBC couldn t get rid of me Medical school, Internal Medicine residency, Clinical Immunology and Allergy fellowship Current
More informationPediatric Allergy Allergy Related Testing
Pediatric Allergy Allergy Related Testing 1 Allergies are reactions that are usually caused by an overactive immune system. These reactions can occur in a variety of organs in the body, resulting in conditions
More informationfirst specific test for identifying and quantifying individual NRL allergens
FITkit The first specific test for identifying and quantifying individual NRL allergens 2 FITkit 3 Measurement of clinically relevant NRL allergens FITkit - The first specific test for identifying and
More informationEnzyme Safety Management: Thanks for joining us today!
Enzyme Safety Management: Thanks for joining us today!.the webinar will begin shortly. The webinar will be recorded. Please make sure to be on mute so that we can ensure a good quality of the audio. 1
More informationPERIOPERATIVE ANAPHYLAXIS: A BRIEF REVIEW
PERIOPERATIVE ANAPHYLAXIS: A BRIEF REVIEW DEC 2011 ANDREW TRIEBWASSER DEPARTMENT OF ANESTHESIA HASBRO CHILDREN S HOSPITAL ADVERSE DRUG REACTIONS (ADR) IN THE PERIOPERATIVE ENVIRONMENT: OVERVIEW most perioperative
More informationTREATMENT OF ANAPHYLACTIC REACTION WITH EPINEPHRINE
TREATMENT OF ANAPHYLACTIC REACTION WITH EPINEPHRINE FILE: JGCDC Background: The Bibb County School System recognizes the growing concern with severe life-threatening allergic reactions to food items, latex,
More informationHOSPITAL CARE MEDICAL DEVICES Surgical Disposables
HOSPITAL CARE MEDICAL DEVICES Surgical Disposables AEROMED STAPLER SKIN GRAFT KNIFE BLADE 3 WAY STOPCOCK EXTENSION TUBING WITH 3-WAY STOPCOCK ENDOTRACHEAL TUBE SAFE-CATH ALL SILICON FOLLEY CATHETER AERO
More informationAssessing the Risk of Laboratory Acquired Allergies
Guideline Created By: Stephanie Thomson, Kelly Eaton, Sonam Uppal & Hollie Burrage Edited By: N/A Workplace Health Services Occupational & Preventive Health Unit Effective date: January 8, 2015 Review
More informationSkin prick testing: Guidelines for GPs
INDEX Summary Offered testing but where Allergens precautions are taken Skin prick testing Other concerns Caution Skin testing is not useful in these following conditions When skin testing is uninterpretable
More informationCommonly Asked Questions About Chronic Hepatitis C
Commonly Asked Questions About Chronic Hepatitis C From the American College of Gastroenterology 1. How common is the hepatitis C virus? The hepatitis C virus is the most common cause of chronic viral
More informationAllergy Immunotherapy in the Primary Care Setting
Allergy Immunotherapy in the Primary Care Setting New York State College Health Association 2008 COMBINED ANNUAL MEETING October 2008 Mary Madsen RN BC University of Rochester Issues in Primary Care Practice
More informationMay 9, For more information about Allergy & Asthma Network contact us at or
May 9, 2018 Allergy & Asthma Network ( Network ) is the nation s leading voice and patient advocate for more than 50 million Americans with allergies and 22 million with asthma. For 32 years, the Network
More informationSCHOOL DISTRICT NO. 51 (BOUNDARY) P O L I C Y
SCHOOL DISTRICT NO. 51 (BOUNDARY) P O L I C Y SECTION TITLE NO. 4020 HEALTH/SAFETY Anaphylaxis (Severe Allergic Reaction) DATE ADOPTED: May 13, 2008 DATE AMENDED: Anaphylaxis is a sudden and severe allergic
More information7/25/2016. Use of Epinephrine in the Community. Knowledge Amongst Paramedics. Knowledge Amongst Paramedics survey of 3479 paramedics
Recognition & Management of Anaphylaxis in the Community S. Shahzad Mustafa, MD, FAAAAI Disclosures Speaker s bureau Genentech, Teva Consultant Genentech, Teva Outline Knowledge gap Definition Pathophysiology
More informationImportant Information About Vaccinia (Smallpox) Vaccine Please Read This Carefully
Important Information About Vaccinia (Smallpox) Vaccine Please Read This Carefully Introduction Vaccinia vaccine, previously known as smallpox vaccine, is highly effective in producing immunity to smallpox
More informationShould you have questions or concerns, please contact the Program Supervisor at the location your child is registered.
Community Services Department, Recreation Division 201 City Centre Drive MISSISSAUGA ON L5B 2T4 mississauga.ca/recreation Dear Parent/Guardian, We are excited to have you join us for camps this season!
More informationPRINCIPLES AND PRACTICES OF ASEPSIS OBJECTIVES
Module E PRINCIPLES AND PRACTICES OF ASEPSIS Role of hands and the environment in disease transmission OBJECTIVES Describe the principles and practice of asepsis. Understand hand hygiene. 1 DEFINING ASEPSIS
More information3/26/2014 OBJECTIVES PRINCIPLES AND PRACTICES OF ASEPSIS DEFINING ASEPSIS MEDICAL ASEPSIS PRINCIPLES OF MEDICAL ASEPSIS
Module E OBJECTIVES Describe the principles and practice of asepsis. PRINCIPLES AND PRACTICES OF ASEPSIS Understand hand hygiene. Role of hands and the environment in disease transmission DEFINING ASEPSIS
More informationScope of Practice Allergy Skin Testing in Australia In relation to revised Medicare Benefits Schedule item numbers effective 1 November 2018
Scope of Practice Allergy Skin Testing in Australia In relation to revised Medicare Benefits Schedule item numbers effective 1 November 2018 A. Introduction The Australasian Society of Clinical Immunology
More informationDr. Janice M. Joneja, Ph.D. FOOD ALLERGIES - THE DILEMMA
Dr. Janice M. Joneja, Ph.D. FOOD ALLERGIES - THE DILEMMA 2002 The Dilemma Accurate identification of the allergenic food is crucial for correct management of food allergy Inaccurate identification of the
More informationNUTS AND BOLTS OF A PHARMACY-BASED IMMUNIZATION CLINIC. Amy Bachyrycz, Pharm.D.
NUTS AND BOLTS OF A PHARMACY-BASED IMMUNIZATION CLINIC Amy Bachyrycz, Pharm.D. Policy and Procedures Manual Licensure/certifications Pharmacy license Pharmacists license CPR certification for each pharmacist
More informationIg Therapy: One Size Does Not Fit All
Ig Therapy: One Size Does Not Fit All Carla Duff, CPNP, MSN, IgCN Advanced Registered Nurse Practitioner University of South Florida Division of Allergy, Immunology, and Rheumatology 1 Objectives Understand
More informationChapter 7 8/23/2016. Asepsis and Infection Control. Asepsis. Asepsis (Cont.) Microorganisms. Infection control and prevention
Chapter 7 Asepsis and Infection Control All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Asepsis Microorganisms Tiny microscopic entities capable
More information2017 Blue Cross and Blue Shield of Louisiana
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationEnd Vinyl Glove Worries. Relax with Lavender *.
Kimberly-Clark * KC100 Lavender * Nitrile Exam Gloves End Vinyl Glove Worries. Relax with Lavender *. Protection You Can Trust. Comfort You Can Feel. Kimberly-Clark * KC100 Lavender * Nitrile Exam Gloves
More informationPOLICY & PROCEDURE Scope Service Wide Program Campus
Eastern Health Draft 220306 Post Frank Thien s Comments POLICY & PROCEDURE Scope Service Wide Program Campus XX Folder: Clinical Policy Manual Index No Sub-Section: Perioperative Services Sponsor: Subject:
More informationADMINISTRATIVE CHECKLIST FOR ANAPHYLAXIS
Appendix 317A ADMINISTRATIVE CHECKLIST FOR ANAPHYLAXIS Information gathering: Physician s information sheet completed Parent consent to give medical treatment form signed Student Care Plan readily available
More informationSHERMOND GLOVE RANGE Your first choice for unbeatable quality and medical protection
INTRODUCING THE HEROND GOVE RANGE Your first choice for unbeatable quality and medical protection Healthcare Excellence About shermond UNbeatable quality and medical Protection edical examination gloves
More informationSupervisors, Department Heads and Principals will:
The Greater Victoria School District is committed to each student s success in learning within a responsive and safe environment. REGULATION 4213 UNIVERSAL PRECAUTIONS Preamble Universal Precautions are
More informationCHAPTER 7 Medical/Surgical Asepsis and Infection Control
CHAPTER 7 Medical/Surgical Asepsis and Infection Control 1 Slide 1 Microorganisms Microscopic. Naturally present on and in the human body and environment. Some microorganisms (pathogens) cause specific
More informationThe Mungo Foundation. Personal Protective Equipment Policy & Procedure
The Mungo Foundation Personal Protective Equipment Policy & Procedure HUMAN RESOURCES DEPARTMENT RESPONSIBLE FOR IMPLEMENTATION ISSUE DATE: February 2009 REVIEW DATE: February 2011 POLICY SECTION Human
More informationBLOODBORNEPATHOGENS. CAP Safety Meetings. Revision: CAP Safety Meetings [Bloodborne Pathogens]
BLOODBORNEPATHOGENS CAP Safety Meetings Revision: 10-2011 2011 Copyright - PEC/Premier Safety Management, Inc. All Rights Reserved Revision: [10-2011] 1 THEBLOODBORNEPATHOGENSSTANDARD The Bloodborne Pathogens
More informationHome Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE
UNIVERSITY OF MICHIGAN HOSPITALS AND HEALTH CENTERS UMHHC-HCS: 253.054 First Approved Date: 3/2010 Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating
More informationEXAM, STERILE, SURGICAL HaNd Protection
EXAM, STERILE, SURGICAL HaNd Protection P R O D U C T C A T A L O G BTLA101 XS 220mm 70mm +/- 10mm BTLA102 S 220mm 80mm +/- 10mm BTLA103 M 230mm 95mm +/- 10mm BTLA104 L 230mm 111mm +/- 10mm BTLA105 XL
More information